The research, published in the journal
Molecular Autism, has been led by Ivon Cuscó and Luis Pérez Jurado, researchers at the
Genetics Unit of the Department of Experimental and Health Sciences at UPF, and members of the
CIBERER network for the study of rare diseases.
A study of all the master's degree final projects - TFMs or dissertations - defended at five
consecutive editions (2006-2010) of the master's degree in Public Health taught jointly by Pompeu
Fabra University (UPF) and the Autonomous University of Barcelona (UAB).
The study, by an international research team in which a fundamental role has been played by the
Institute of Evolutionary Biology (IBE), a joint CSIC and UPF centre, and the National Centre for
Genome Analysis (CNAG), has been published in the 10 April edition of the journal Science.
The award aims to recognize and showcase the research of excellence conducted in Spain.
According to the work of scientist Ricard Solé, ICREA researcher at the Department of Experimental
and Health Sciences, recently published in the journal
The Spanish Ministry of Health, Social Services and Equality has published in the Official State
Gazette the decision of 4 December awarding
eleven grants to pursue research projects on drug addiction, within the call of
the National Drug Plan. At this call, researchers from the Department of Experimental and Health
Sciences have received
two of these grants which started in early 2015 for a period of three years.
A new computer tool lets the interaction between small molecules and thousands of proteins be
predicted to study their relationship to different diseases. The study has proven that many of
these small molecules or chemical probes are not as selective as believed, but instead interact
with multiple proteins, which could lead to confusion in experimental results. Understanding these
interactions is key to developing more efficient and safer pharmaceuticals
Intelligence Led Assessment of Pharmaceuticals in the Environment starts on
February 2015 with a kick off meeting at Barcelona Biomedical Research Park (PRBB) and the
participation of the GRIB research groups of
Integrative Biomedical Informatics (IBI) and
PharmacoInformatics (PhI) of Institut Hospital del Mar d'Investigacions
Mèdiques (IMIM) and Pompeu Fabra University (UPF).
For her research into ageing. UPF is the only institution to have had nominees at the five editions
held to date. The general public can vote until 28 February for the most relevant research in 2014.
Personalized treatments for the hemiplegic migraine will be on study by José M.
Fernández-Fernández, member of the Laboratory of Molecular Physiology and Channelopathies at CEXS
and the principal investigator of the study.